advanced search
Sophie Lelias
Associate Director of Business Development
BD (Becton Dickinson & Company)

Is this your profile?

About

Sophie Lelias is an Associate Director of Business Development at BD BioPharmaceutical Systems. In her role, she drives end-to-end business development across the Prefillable Solutions portfolio, from early concept through commercialisation. Prior to this, Ms Lelias led global strategic portfolio marketing for the Biologics Prefillable Syringe portfolio, including the BD Hypak™ for Biotech and BD Neopak™ Glass PFS platforms.

She collaborates closely with cross-functional teams globally to deliver value-driven solutions to pharmaceutical partners. Ms Lelias has held roles across the BD Interventional – Surgery, BD Medical – Infusion Preparation and Delivery and BD Medical Pharmaceutical Systems businesses, with a strong focus on strategic innovation marketing. She holds a Bachelor’s degree in Public Health from Brown University (Providence, RI, US).

Contributions

DUAL CHAMBER
DE-RISKING A NOVEL VALVE COMPONENT FOR USE WITH STANDARD SYRINGE AND AUTOINJECTOR PLATFORMS
Marc Flippe and Sophie Lelias introduce a novel valve component designed to enable dual-chamber functionality within standard syringe and autoinjector platforms. Developed through a comprehensive modelling and development framework, the BD dual-injection syringe system provides a scalable solution to dual-chamber injection that reduces the burden of change by preserving compatibility with established container formats and device architectures.
Top